WELLESLEY, Mass.--(BUSINESS WIRE)--NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body’s ability to deliver oxygen to diseased tissues, today announced that Gerard (Rod) Riedel, PhD, has been appointed Vice President, Regulatory Affairs and Program Management.
